Clinical Trials Directory

Trials / Completed

CompletedNCT02524977

Impact of an Atrial Fibrillation Decision Support Tool (AFDST) on Thromboprophylaxis for Atrial Fibrillation

Impact of a Quality Improvement And Education Initiative on 'Appropriate' Use of Anticoagulant Therapy in Patients With Atrial Fibrillation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
University of Cincinnati · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Study objective was to improve decision-making and thromboprophylaxis for patients with Atrial Fibrillation (AF) by developing and implementing a computerized decision support tool for individual patient-level decision-making about oral anticoagulant therapy. To accomplish these goals, the investigators studied the incremental impact of adding a quality-improvement (QI) intervention to an educational package (for practice staff and clinicians) using a computerized aid, the Atrial Fibrillation Decision Support Tool (AFDST) for individual patient-level decision-making about oral anticoagulant therapy in patients with non-valvular AF. The decision support tool incorporates individual patients' risk factor profiles for ischemic stroke and bleeding and provides a recommendation for treatment based upon the projected quality-adjusted life expectancy gained or lost with the addition of either oral anticoagulant therapy or aspirin compared with no thromboprophylaxis.

Detailed description

Setting - Cluster randomized trial. Setting - Primary care practices of an integrated healthcare system. Participants - 1,493 adults with non-valvular AF seen between April 2014 and March 2015. Intervention - Treatment recommendations were made by an Atrial Fibrillation Decision Support Tool (AFDST) based on projections for quality-adjusted life expectancy calculated by a decision analytic model that integrates patient-specific risk factors for stroke and hemorrhage.

Conditions

Interventions

TypeNameDescription
BEHAVIORALDecision SupportProvision of recommended antithrombotic therapy based on atrial fibrillation decision support tool that uses both stroke and bleeding risk
BEHAVIORALEducational Intervention OnlyEducational conference series

Timeline

Start date
2012-12-01
Primary completion
2016-03-01
Completion
2016-03-01
First posted
2015-08-17
Last updated
2018-10-25
Results posted
2018-10-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02524977. Inclusion in this directory is not an endorsement.